GE HealthCare Technologies Inc. $GEHC Position Trimmed by Coronation Fund Managers Ltd.

Key Points

• Coronation Fund Managers cut its position in GE HealthCare by 80.3% in Q4, selling 264,603 shares and retaining 65,097 shares valued at about $5.34 million.
• Meanwhile, several large funds (Dodge & Cox, Capital Research, Hotchkis & Wiley, Dimensional, VanEck) increased stakes in prior quarters and institutional ownership remains high at 82.06%.
• GE HealthCare beat Q4 estimates with $1.44 EPS and $5.70B revenue (up 7.1% YoY), issued FY26 guidance of 4.95–5.15 EPS, trades near $68.89 with a $31.4B market cap, and carries an average analyst target of $89.77.

Coronation Fund Managers Ltd. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 80.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 65,097 shares of the company's stock after selling 264,603 shares during the quarter. Coronation Fund Managers Ltd.'s holdings in GE HealthCare Technologies were worth $5,339,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Dodge & Cox grew its stake in shares of GE HealthCare Technologies by 16.8% in the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company's stock valued at $2,066,550,000 after buying an additional 3,949,361 shares in the last quarter. Capital Research Global Investors grew its stake in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company's stock valued at $1,875,400,000 after buying an additional 4,998,154 shares in the last quarter. Hotchkis & Wiley Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company's stock valued at $633,271,000 after buying an additional 1,232,828 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of GE HealthCare Technologies by 8.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company's stock valued at $402,647,000 after buying an additional 438,439 shares in the last quarter. Finally, Van ECK Associates Corp grew its stake in shares of GE HealthCare Technologies by 3.2% in the 3rd quarter. Van ECK Associates Corp now owns 4,497,827 shares of the company's stock valued at $337,787,000 after buying an additional 139,404 shares in the last quarter. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 1.4%

GEHC opened at $68.89 on Friday. The business has a 50 day moving average price of $74.65 and a 200 day moving average price of $77.77. GE HealthCare Technologies Inc. has a twelve month low of $66.95 and a twelve month high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The firm has a market cap of $31.43 billion, a P/E ratio of 15.11, a price-to-earnings-growth ratio of 1.54 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period in the previous year, the company earned $1.45 EPS. The company's revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 5 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies's payout ratio is 3.07%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Bank of America boosted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a "neutral" rating in a research note on Monday, January 5th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an "overweight" rating in a research note on Thursday, February 5th. UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and boosted their price target for the company from $73.00 to $77.00 in a research note on Thursday, January 15th. Mizuho lowered their price target on GE HealthCare Technologies from $95.00 to $90.00 and set an "outperform" rating for the company in a research note on Monday, April 13th. Finally, Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a "buy" rating in a research note on Wednesday, February 4th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $89.77.

GE HealthCare Technologies Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.